Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Flexible regions govern promiscuous binding of IL-24 to receptors IL-20R1 and IL-22R1

J. Zahradník, L. Kolářová, Y. Peleg, P. Kolenko, S. Svidenská, T. Charnavets, T. Unger, JL. Sussman, B. Schneider,

. 2019 ; 286 (19) : 3858-3873. [pub] 20190612

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
CZ.02.1.01/0.0/0.0/16_013/0001777 MEYS, Ministry of education, youth, and sports of the Czech Republic - International
CZ.1.05/1.1.00/02.0109 MEYS, Ministry of education, youth, and sports of the Czech Republic - International
LM2015043 MEYS, Ministry of education, youth, and sports of the Czech Republic - International
RVO 86652036 Akademie Věd České Republiky - International
16-20507S Grantová Agentura České Republiky - International

E-resources Online Full text

NLK Free Medical Journals from 2005 to 1 year ago
Medline Complete (EBSCOhost) from 2005-01-01 to 1 year ago
Wiley Free Content from 2005 to 1 year ago

Interleukin 24 (IL-24) is a cytokine with the potential to be an effective treatment for autoimmune diseases and cancer. However, its instability and difficulties in its production have hampered detailed biological and biophysical studies. We approached the challenges of IL-24 production by using the PROSS algorithm to design more stable variants of IL-24. We used homology models built from the sequences and known structures of IL-20 and IL-19 and predicted and produced several extensively mutated IL-24 variants that were highly stable and produced in large yields; one of them was crystallized (IL-24B, PDB ID 6GG1; 3D Interactive at http://proteopedia.org/w/Journal: FEBS_Journal:1). The mutated variants, however, lost most of their binding capacity to the extracellular parts of cognate receptors. While the affinity to the receptor 2 (IL-20R2) was preserved, the variants lost affinity to IL-20R1 and IL-22R1 (shared receptors 1). Back engineering of the variants revealed that reintroduction of a single IL-24 wild-type residue (T198) to the patch interacting with receptors 1 restored 80% of the binding affinity and signaling capacity, accompanied by an acceptable drop in the protein stability by 9 °C. Multiple sequence alignment explains the stabilizing effect of the mutated residues in the IL-24 variants by their presence in the related and more stable cytokines IL-20 and IL-19. Our homology-based approach can enhance existing methods for protein engineering and represents a viable alternative to study and produce difficult proteins for which only in silico structural information is available, estimated as >40% of all important drug targets.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025608
003      
CZ-PrNML
005      
20201222154008.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.14945 $2 doi
035    __
$a (PubMed)31152679
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zahradník, Jiří $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic. Weizmann Institute of Science, Rehovot, Israel.
245    10
$a Flexible regions govern promiscuous binding of IL-24 to receptors IL-20R1 and IL-22R1 / $c J. Zahradník, L. Kolářová, Y. Peleg, P. Kolenko, S. Svidenská, T. Charnavets, T. Unger, JL. Sussman, B. Schneider,
520    9_
$a Interleukin 24 (IL-24) is a cytokine with the potential to be an effective treatment for autoimmune diseases and cancer. However, its instability and difficulties in its production have hampered detailed biological and biophysical studies. We approached the challenges of IL-24 production by using the PROSS algorithm to design more stable variants of IL-24. We used homology models built from the sequences and known structures of IL-20 and IL-19 and predicted and produced several extensively mutated IL-24 variants that were highly stable and produced in large yields; one of them was crystallized (IL-24B, PDB ID 6GG1; 3D Interactive at http://proteopedia.org/w/Journal: FEBS_Journal:1). The mutated variants, however, lost most of their binding capacity to the extracellular parts of cognate receptors. While the affinity to the receptor 2 (IL-20R2) was preserved, the variants lost affinity to IL-20R1 and IL-22R1 (shared receptors 1). Back engineering of the variants revealed that reintroduction of a single IL-24 wild-type residue (T198) to the patch interacting with receptors 1 restored 80% of the binding affinity and signaling capacity, accompanied by an acceptable drop in the protein stability by 9 °C. Multiple sequence alignment explains the stabilizing effect of the mutated residues in the IL-24 variants by their presence in the related and more stable cytokines IL-20 and IL-19. Our homology-based approach can enhance existing methods for protein engineering and represents a viable alternative to study and produce difficult proteins for which only in silico structural information is available, estimated as >40% of all important drug targets.
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a interleukiny $x metabolismus $7 D007378
650    _2
$a vazba proteinů $7 D011485
650    _2
$a receptory interleukinů $x metabolismus $7 D018123
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolářová, Lucie $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Peleg, Yoav $u Weizmann Institute of Science, Rehovot, Israel.
700    1_
$a Kolenko, Petr $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic. Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
700    1_
$a Svidenská, Silvie $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Charnavets, Tatsiana $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
700    1_
$a Unger, Tamar $u Weizmann Institute of Science, Rehovot, Israel.
700    1_
$a Sussman, Joel L $u Weizmann Institute of Science, Rehovot, Israel.
700    1_
$a Schneider, Bohdan $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 286, č. 19 (2019), s. 3858-3873
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31152679 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154004 $b ABA008
999    __
$a ok $b bmc $g 1599753 $s 1116294
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 286 $c 19 $d 3858-3873 $e 20190612 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
GRA    __
$a CZ.02.1.01/0.0/0.0/16_013/0001777 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
GRA    __
$a CZ.1.05/1.1.00/02.0109 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
GRA    __
$a LM2015043 $p MEYS, Ministry of education, youth, and sports of the Czech Republic $2 International
GRA    __
$a RVO 86652036 $p Akademie Věd České Republiky $2 International
GRA    __
$a 16-20507S $p Grantová Agentura České Republiky $2 International
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...